A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®

Clinical trial NCT00885365 · COMPLETED

Trial details

NCT number: NCT00885365
Sponsor: Chiesi Farmaceutici S.p.A.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2009-04-01
Primary completion: 2010-04-01
Enrollment: 324

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.